Dr Reddy's Laboratories Limited on Thursday announced a change in the senior leadership team. The company has appointed former president and CEO of Enzymotec, Erez Israeli, as the chief operating officer and global head of generics and PSAI (pharmaceutical services and active ingredients).
He will replace Abhijit Mukherjee, who is retiring on March 31, 2018 after a 15-year stint at Dr Reddy's. For the first time, the company is bringing in a senior management hand from outside India though a couple of senior people from global pharma industry have been currently serving on the board as independent, non-wholetime directors.
Israeli's entry comes

)